Corrigendum: Advanced NSCLC Patients with EGFR T790M Harbouring TP53 R273C or KRAS G12V Cannot Benefit from Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy User montaukwhaler, in the non small cell lung cancer subreddit, 19 Jun 2023